Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $170.52 | 1 | 69.5% |
| Education | $74.79 | 6 | 30.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $170.52 | 1 | $0 (2019) |
| Seattle Genetics, Inc. | $36.87 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $14.95 | 1 | $0 (2020) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| PFIZER INC. | $11.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $14.95 | 1 | E.R. Squibb & Sons, L.L.C. ($14.95) |
| 2019 | $181.57 | 2 | Abbott Laboratories ($170.52) |
| 2018 | $36.87 | 3 | Seattle Genetics, Inc. ($36.87) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 07/01/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $14.95 | General |
| Category: Oncology | ||||||
| 12/18/2019 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2019 | Abbott Laboratories | Perclose ProGlide suture mediated closure system (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $170.52 | General |
| Category: Vascular | ||||||
| 11/15/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 09/05/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 07/19/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 325 | 756 | $209,375 | $70,036 |
| 2022 | 6 | 308 | 706 | $184,130 | $62,016 |
| 2021 | 7 | 295 | 776 | $196,315 | $66,640 |
| 2020 | 6 | 333 | 947 | $220,682 | $67,417 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 139 | $48,140 | $15,993 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 205 | $48,285 | $15,081 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 86 | $29,240 | $9,983 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 122 | $28,130 | $8,940 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 45 | $20,385 | $6,417 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 91 | $15,240 | $6,087 | 39.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 51 | $12,645 | $5,132 | 40.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $7,310 | $2,403 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 136 | $45,205 | $15,539 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 165 | $37,815 | $12,276 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 115 | $26,165 | $8,644 | 33.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 69 | $17,385 | $5,968 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 50 | $16,400 | $5,904 | 36.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $17,940 | $5,871 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 92 | $16,700 | $5,562 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 43 | $6,520 | $2,253 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 235 | $52,875 | $18,133 | 34.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 95 | $29,925 | $11,458 | 38.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 149 | $30,545 | $9,109 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 111 | $24,975 | $8,840 | 35.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 50 | $15,750 | $6,340 | 40.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 33 | $18,975 | $5,557 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 61 | $8,845 | $2,862 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 31 | $9,145 | $2,742 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $5,280 | $1,598 | 30.3% |
About Dr. Jason Chang, M.D
Dr. Jason Chang, M.D is a Hematology & Oncology healthcare provider based in Southington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174739072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Chang, M.D has received a total of $245.31 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($170.52).
As a Medicare-enrolled provider, Chang has provided services to 1,261 Medicare beneficiaries, totaling 3,185 services with total Medicare billing of $266,109. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Southington, CT
- Active Since 05/15/2007
- Last Updated 08/01/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1174739072
Products in Payments
- Perclose ProGlide suture mediated closure system (Device) $170.52
- ADCETRIS (Biological) $36.87
- OPDIVO (Biological) $14.95
- LORBRENA (Drug) $11.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.